Sterile Barrier, Sterilization Validation and Shelf Life: Organizing Stability Evidence
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
In the UAE, shelf life is one set of data used in two places: at registration it proves that the product maintains its performance and sterile state through the labelled expiry date, and at customs clearance it decides whether the shipment can enter. The rules on both sides must be designed together — the EDE import permit service page states explicitly that the remaining shelf life at arrival must not fall below two thirds of the total shelf life; for imports from fenced free zones, a valid marketing office licence and a GSP certificate issued by EDE are additionally required, with a shelf life of at least 12 months. Preparing shelf life data only for the registration side can leave goods stranded at the port.
- Shelf life data serve both the registration stage and the customs clearance stage.
- At arrival, the remaining shelf life must be at least two thirds of the total shelf life.
- Free zone imports additionally require a valid marketing office licence, an EDE-issued GSP certificate, and at least 12 months of shelf life.
- Sterilization validation, sterile barrier validation, and shelf life validation form one closed evidence chain.
- Import permits are valid for only 2 months, so timing must be planned backwards from arrival.
2. Legal basis
The regulatory basis combines the EDE import permit service page with subparagraphs (b) and (g) of Article 6(1) of Federal Decree-Law No. 38 of 2024. The table below reproduces the instruments cited in the source material and their key points.
| EDE service page: Permit to Import Medical items and products | Permit to Import Medical items and products (service page, no instrument number) | Currently published on the EDE website | Import conditions: shelf life requirements | The remaining shelf life at arrival must not be below two thirds of the total shelf life; imports from fenced free zones require a valid marketing office licence and a GSP certificate issued by EDE, with a shelf life of at least 12 months |
| EDE service page: Permit to Import Medical items and products | Permit to Import Medical items and products (service page, no instrument number) | Currently published on the EDE website | Service timelines and validity | Initial import 3 working days, arrival clearance 2 working days; application fee AED 100; the import permit is valid for 2 months from the date of issue |
| UAE Federal Decree-Law on the Regulation of Medical Products, Pharmacists and Pharmaceutical Establishments | Federal Decree-Law No. 38 of 2024 | Published in the Official Gazette on 2024-10-14; entered into force on 2025-01-02 | Article 6(1)(b) and (g) | (b) quality assurance, product traceability, and post-market follow-up systems; (g) complete information on inner and outer packaging and the package insert, compliant with the EDE labelling guidance |
3. Expert insights
Insight 1: The two-thirds rule is a hard clearance line that disciplines production and logistics pacing. For a product with a total shelf life of 2 years, at least approximately 16 months must remain at arrival (practical estimate, converted at the two-thirds ratio). This compresses the time from completion of sterilization to shipment substantially. Our judgment is that Chinese manufacturers often schedule production to domestic distribution rhythms, so the remaining shelf life is already insufficient when the goods reach the Dubai port; this kind of loss cannot be remedied at clearance and can only be solved at the production scheduling stage.
Insight 2: The free zone route carries a stricter 12-month requirement, tied to the GSP certificate. For imports from fenced free zones, a valid marketing office licence and a GSP certificate issued by EDE are required, with a shelf life of at least 12 months. Our recommendation is that where the remaining shelf life of a shipment falls between 12 months and the two-thirds converted value, the general import route should be used instead of the free zone route to avoid touching the higher threshold; this decision should be made at the stocking stage, not after arrival.
Insight 3: The registration-side shelf life data must be able to support the labelled value. Sterilization validation, sterile barrier packaging validation, and shelf life validation together form a complete chain; if any one is missing, the labelled shelf life lacks a basis. The import permit is valid for 2 months from issue, the initial import takes 3 working days, and arrival clearance takes 2 working days — these windows are all short, which means documentation problems must be fully resolved before shipment; they cannot be left to be remedied after arrival.
4. Practical recommendations
- Reverse-schedule production and shipment from the rule that the remaining shelf life at arrival must not fall below two thirds of the total, and write the milestones into the production plan.
- For the fenced free zone route, confirm in advance that the marketing office licence and the EDE GSP certificate are ready, and reserve at least 12 months of shelf life.
- Submit sterilization validation, packaging validation, and shelf life validation evidence together as a closed loop; do not submit only one of the three.
- The import permit is valid for only 2 months; schedule the application backwards from the arrival date to avoid reapplying after the permit expires.
- Keep the expiry date stated on the label consistent with the shelf life validation conclusion; never state an expiry beyond the validated range.
- For biological-source products or products containing blood, plasma, or human tissue, arrange the EDE batch release certificate separately and schedule it apart from ordinary sterile devices.
5. Verification checklist
- □ The sterilization validation report covers the sterilization method and loading configuration of the products to be registered
- □ The sterile barrier packaging validation report is complete, and the packaging specifications match the commercial packaging
- □ The shelf life validation conclusion supports the expiry date stated on the label
- □ Shipment milestones converted under the two-thirds rule are written into the production and booking plans
- □ The GSP certificate and the marketing office licence for the free zone route are within their validity periods
- □ The import permit application timing has been calculated backwards from the arrival date against the 2-month validity
- □ Processing of the EDE batch release certificate for biological-source products has been included in the schedule
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the United Arab Emirates. Our team prepares MOHAP-compliant dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us